Aim Of Study: To describe the clinical, therapeutic and evolutionary profile of patients followed for rifampicin-resistant pulmonary tuberculosis (RR-TB) at the Regional Hospital Centre (RHC) of Maradi (Niger) from 2014 to 2018.
Methods: We conducted a retrospective and descriptive study based on the records of patients followed for Multidrug-resistant tuberculosis (MDR-TB) between January 1, 2014 and June 30, 2018 at the resistant tuberculosis management unit in Maradi (Niger). This unit is located within the RHC of Maradi and has a capacity of 20 beds in 4 wards.
Objective: Objective of this study was to determine the frequency of tuberculosis (TB) and the impact of immunosuppression in patients living with HIV (PvVIH) monitored at the Regional Hospital Center (CHR) of Maradi.
Methods: That was a retrospective study based on the medical records of PvVIH followed in the infectious diseases department of the CHR of Maradi. All HIV-positive adults were included in regular consultations between January 2013 and September 2018.
Introduction: This study aimed to describe the epidemiological, clinical and evolutionary profile of patients treated for tuberculosis at the Regional Hospital of Maradi.
Methods: We conducted a retrospective, descriptive and analytical study of data from the medical records of patients treated for tuberculosis from 1 January 2015 to 31 December 2017.
Results: A total of 595 patients were followed (406 men, 68.
In the Maradi region, despite multiple efforts to reduce maternal mortality the in-hospital maternal mortality ratio (HMMR) remains high. We sought to determine the factors related to maternal mortality in seven maternity units in this region. A retrospective study reviewed records of deliveries from January, 2008, through December, 2010.
View Article and Find Full Text PDF